Private equity firm Linden Capital Partners acquired Collagen Matrix, manufacturer of xenograft mineral- and collagen-based products used for tissue and bone repair and regeneration in orthopedic, sports medicine, dental and neurosurgery applications.
Collagen Matrix’s portfolio includes SCC™ Synthetic Bone Grafts for orthopedics, OssiMend® bone graft products in various formats for orthopedics and spine, and TenoMend™ collagen wrap for tendon injuries.
Linden focuses exclusively on medical products, contract and private label manufacturing and the dental and orthopedic sectors. In January 2019, the firm acquired Avalign Technologies, a contract manufacturer of implants, instruments, cutting tools, specialty instruments and cases/trays.
Private equity firm Linden Capital Partners acquired Collagen Matrix, manufacturer of xenograft mineral- and collagen-based products used for tissue and bone repair and regeneration in orthopedic, sports medicine, dental and neurosurgery applications.
Collagen Matrix's portfolio includes SCC™ Synthetic Bone Grafts for orthopedics, OssiMend®...
Private equity firm Linden Capital Partners acquired Collagen Matrix, manufacturer of xenograft mineral- and collagen-based products used for tissue and bone repair and regeneration in orthopedic, sports medicine, dental and neurosurgery applications.
Collagen Matrix’s portfolio includes SCC™ Synthetic Bone Grafts for orthopedics, OssiMend® bone graft products in various formats for orthopedics and spine, and TenoMend™ collagen wrap for tendon injuries.
Linden focuses exclusively on medical products, contract and private label manufacturing and the dental and orthopedic sectors. In January 2019, the firm acquired Avalign Technologies, a contract manufacturer of implants, instruments, cutting tools, specialty instruments and cases/trays.
Copy to clipboard 
